
Hemant Surgical Industries Ltd. (HSIL) Share Price Near 52-Week High as HSIL Trades at Rs 665
Updated: 9 Oct 2026 • 3:34 pm
Posted by:

HSIL Share Price is trading at Rs 665, up 4.59% from the previous close, and remains close to its 52-week high with a market capitalisation of Rs 967.04 Cr. Hemant Surgical Industries Ltd. Share Price moved within a day range of Rs 604.05 to Rs 667.5, while latest Univest data confirms the price event but does not establish a company-specific catalyst. For readers tracking HSIL Share Price Today, the move is relevant because it places the stock near its yearly high while the broader HSIL Stock News flow remains centred on verified price action rather than a stated trigger.
HSIL Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 665 |
| Previous Close | Rs 635.8 |
| Today's Move | +Rs 29.2 (+4.59%) |
| Open | Rs 610 |
| High | Rs 667.5 |
| Low | Rs 604.05 |
| Market Capitalisation | Rs 967.04 crore |
Hemant Surgical Industries Ltd. (HSIL) traded at Rs 665 versus the previous close of Rs 635.8, a rise of 4.59%. The stock opened at Rs 610, reached a high of Rs 667.5 and touched a low of Rs 604.05.
HSIL Share Price Today opened at Rs 610, moved to a low of Rs 604.05, and touched a high of Rs 667.5. The current price of Rs 665 is Rs 29.2 above the previous close of Rs 635.8, which equals a 4.59% rise. That places HSIL Share Price very close to its 52-week high, with the gap to the day’s high now narrow. For readers scanning HSIL Share Price Today and HSIL Stock News, the key point is straightforward: the latest price action confirms a near 52-week high event, while the latest Univest data does not assign a separate company event or explanation. The stock’s move also keeps HSIL Share News and HSIL Share Price News in focus for market watchers comparing daily price bands and yearly highs.
The 52-week high context matters because HSIL Share Price is already trading above the previous close and near the top of the current day’s range. The current gap between the current price and the 52-week high is small enough to keep the stock on the radar of readers following 52 Week High Stocks, Stocks in News and Market Movers in the Indian Stock Market. HSIL Share Price Today therefore reads as a price event first and a story later: the facts show a strong intraday position, but the data does not identify a catalyst. Univest continues to present the stock as a verified market event rather than a narrative guess.
Hemant Surgical Industries Ltd. (HSIL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 967.04 crore |
| P/E Ratio | 50.81x |
| P/B Ratio | 6.42x |
| ROE | 12.73% |
| ROCE | 13.58% |
| EPS | Rs 12.51 |
| Book Value Per Share | Rs 98.98 |
| Dividend Yield | 0% |
Hemant Surgical Industries Ltd. (HSIL) fundamental metrics show P/E 50.81x, P/B 6.42x, ROE 12.73%, ROCE 13.58%. These figures provide context only and are not a buy or sell signal.
Hemant Surgical Industries Ltd. has a market capitalisation of Rs 967.04 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 50.81x, P/B at 6.42x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.73% and ROCE of 13.58%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 12.51, book value per share of Rs 98.98, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.04x, median ROE of 14.07%, median ROCE of 15.05%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Medical Equipment/Supplies/Accessories |
| Benchmark Scope | same industry |
| Company P/E Ratio | 50.81x |
| Benchmark Median P/E | 30.04x |
| Benchmark Average P/E | 83.38x |
| Benchmark P/E Range | 0x to 934.27x |
| Company P/B Ratio | 6.42x |
| Benchmark Median P/B | 3.5x |
| Company ROE | 12.73% |
| Benchmark Median ROE | 14.07% |
| Company ROCE | 13.58% |
| Benchmark Median ROCE | 15.05% |
| Company Market Capitalisation | Rs 967.04 crore |
| Benchmark Median Market Cap | Rs 167.68 crore |
Hemant Surgical Industries Ltd. (HSIL) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.
Hemant Surgical Industries Ltd. (HSIL) has a P/E ratio of 50.81x, which is above the benchmark median of 30.04x, a difference of +69.14%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Hemant Surgical Industries Ltd. (HSIL) has a ROE of 12.73%, which is below the benchmark median of 14.07%, a difference of -9.52%. Hemant Surgical Industries Ltd. (HSIL) has a ROCE of 13.58%, which is below the benchmark median of 15.05%, a difference of -9.77%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| LAXMI DENTAL LIMITED | LAXMIDENTL | 1,085.73 | 34.26 | 4.31 | 11.95 | 13.29 |
| 3B Blackbio Dx Ltd. | 3BBLACKBIO | 1,378.89 | 23.68 | 3.94 | 20.22 | 25.9 |
| Osel Devices Ltd. | OSELDEVICE | 653.95 | 22.36 | 5.97 | 30.09 | 31.15 |
| Q-LINE BIOTECH LIMITED | QLINE | 1,596.47 | 27.45 | 6.04 | 25.55 | 22.23 |
| Prevest Denpro Ltd. | PREVEST | 482.04 | 21.02 | 3.5 | 17.79 | 24.21 |
Hemant Surgical Industries Ltd. (HSIL) has a P/E ratio of 50.81x compared with the displayed peer median of 23.68x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.73% compares with a peer median of 20.22% across the companies shown in the table. ROCE stood at 13.58% versus the displayed peer median of 24.21%, providing a capital-efficiency comparison. Hemant Surgical Industries Ltd. (HSIL) has a market capitalisation of Rs 967.04 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching HSIL
- HSIL Share Price is trading at Rs 665, above the previous close of Rs 635.8 by Rs 29.2.
- The stock is near its 52-week high, with the day’s high at Rs 667.5.
- HSIL Market Cap stands at Rs 967.04 Cr.
- HSIL P/E is 50.81 versus the industry median of 30.04.
- HSIL ROE is 12.73% and ROCE is 13.58%, both below the industry medians.
About Hemant Surgical Industries Ltd.
Hemant Surgical Industries Ltd. operates in the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. HSIL Share Price is therefore being tracked within a healthcare equipment context rather than a broad general-market bucket. For HSIL Share Price Today readers, the company name, sector classification and industry classification are the main verified profile points available here. Univest uses these identifiers to connect HSIL Stock News, HSIL Share News and HSIL Latest News to the correct listed entity.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What is HSIL Share Price today?
Ans. HSIL Share Price is Rs 665 as of 09 October 2026 at 3:32 PM IST. It is up 4.59% from the previous close of Rs 635.8, keeping HSIL Share Price Today near its 52-week high.
Why is HSIL Share Price in focus?
Ans. HSIL Share Price is in focus because it is trading close to its 52-week high. The latest Univest data confirms the price event, but it does not establish a company-specific catalyst for the move.
How far is HSIL Share Price from the day’s high?
Ans. HSIL Share Price touched Rs 667.5 during the day and was at Rs 665 in the latest update. That leaves the stock very close to the day’s high and near its yearly high zone.
What is HSIL market capitalisation?
Ans. HSIL Market Cap is Rs 967.04 Cr. This places the company above the same-industry median market capitalisation of Rs 167.68 Cr, though below the broader peer average in the benchmark set.
What does HSIL Fundamental Analysis show?
Ans. HSIL Fundamental Analysis shows a P/E of 50.81, P/B of 6.42, ROE of 12.73%, ROCE of 13.58%, EPS of Rs 12.51 and book value of Rs 98.98. Dividend yield is 0.
How does HSIL compare with industry peers?
Ans. HSIL Share Price sits beside peers with lower and higher valuations. Its P/E is above Prevest Denpro, Osel Devices and 3B Blackbio, while its ROE and ROCE are below some of those peers.
Track HSIL Share Price on Univest
Use Hemant Surgical Industries Ltd. (HSIL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track HSIL Share Price on Univest for live price updates, market cap, valuation ratios, 52-week levels, financial ratios and broader market insights. Users following HSIL Share Price Today can also review company pages, sector context and peer comparisons in one place through Univest. This keeps HSIL Stock News and HSIL Share Price Update searches grounded in verified numbers.
Recent Articles

Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
13 November 2026

Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
13 November 2026

Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
13 November 2026

Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
13 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
SC Agrotech Bonus Issue and Stock Split: 4:5 Bonus and 1:10 Split Proposed as the Stock Locks a 5% Upper Circuit at Rs 62.38, Q2 Profit Up 48 Times and What Shareholders Should Check Before the 11 December EGM

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





